Oral Ketamine Tablets vs Capsules: What's the Difference?

Tablets Dissolve in the Mouth, Capsules Are Swallowed

The main difference between oral ketamine tablets and capsules comes down to route of absorption. Compounded ketamine tablets are usually designed to dissolve or be held under the tongue (sublingual) or against the inner cheek (buccal), while capsules are swallowed whole and absorbed through the stomach and intestines like a standard pill. That single difference changes how fast the drug takes effect, how much of it actually reaches your bloodstream, and how much converts to norketamine, ketamine's active metabolite, before it starts working.

Both forms are compounded medications, meaning a licensed pharmacy prepares them to a prescriber's exact specifications rather than a manufacturer mass-producing them. Oral ketamine for depression and other off-label uses is not FDA-approved; only esketamine, sold as Spravato, holds FDA approval for treatment-resistant depression, and that is a nasal spray, not a tablet or capsule. This article is educational information, not medical advice. Which form fits your protocol is a decision to make with your prescriber, not on your own.

How Compounding Pharmacies Prepare Each Form

A compounding pharmacy mixes ketamine hydrochloride powder into a specific dosage form based on a prescriber's order, adjusting strength, shape, and release method for an individual patient rather than filling a mass-produced prescription. For oral ketamine protocols, that usually means one of three related forms: rapid-dissolve tablets, troches (sometimes called lozenges), or capsules. Tablets and troches are formulated to break down in the mouth over roughly 10 to 15 minutes so the drug can absorb through oral tissue; see our guide on what ketamine troches are for how that form compares to tablets specifically.

Capsules contain a measured powder dose inside a shell and are swallowed with water, the same way you would take most prescription medications. There is no under-the-tongue hold time and no direct absorption through the mouth, so the entire dose has to survive the stomach and pass through the liver before reaching general circulation.

Why Absorption Differs: First-Pass Metabolism

First-pass metabolism is the process by which the liver breaks down a portion of an orally swallowed drug before it reaches the bloodstream, and it is the main reason capsules and sublingual tablets behave differently. When ketamine is swallowed in capsule form, it travels through the stomach and intestines and then through the liver's portal circulation, where enzymes convert a large share of it into norketamine before the remainder reaches systemic circulation.

Pharmacokinetic research indexed on PubMed has repeatedly found that swallowed oral ketamine has low and variable bioavailability, commonly cited in roughly the 16 to 24 percent range, because of this first-pass effect. Sublingual and buccal administration lets a portion of the dose absorb directly through blood vessels in the mouth, skipping that initial liver pass, which is why sublingual ketamine studies have reported somewhat higher bioavailability, often in the 25 to 30 percent range, along with a faster rise in blood levels. Our guide to peak plasma levels covers how quickly each route reaches its highest concentration and why that timing matters for dosing decisions.

These pharmacokinetic figures come from small studies with real individual variability, so read them as a general pattern rather than a guarantee of what any one patient will absorb.

Dosing Precision and the Norketamine Question

Norketamine is ketamine's main active metabolite, produced mainly by the liver, and it has its own activity at NMDA receptors along with a longer half-life than the parent drug. Because capsules undergo more complete first-pass metabolism, they typically generate a higher ratio of norketamine to ketamine in the bloodstream than sublingual tablets do. Our explainer on norketamine's role in tablet effects covers what that metabolite does and why researchers are still working out how much it contributes to the antidepressant response versus the dissociative side effects.

In practice, this means the same milligram dose can feel different depending on the form. Compounding pharmacies often supply tablets in several strengths so a prescriber can titrate the dose gradually and watch for both response and side effects. Capsules can usually be compounded at custom strengths too, but adjusting a swallowed dose still means waiting on slower, more variable GI absorption to give feedback. Whichever form is used, a prescriber typically checks blood pressure and heart rate around dosing, since ketamine can raise both; see how ketamine tablets affect blood pressure and heart rate for what that monitoring usually looks like. If you're prescribed tablets for home use, our guide to oral ketamine tablets at home safety outlines the guardrails a prescriber-managed protocol typically includes.

Cost and Insurance Coverage

Neither tablets nor capsules of compounded oral ketamine are guaranteed insurance coverage, because both are prescribed off-label and dispensed by a compounding pharmacy rather than sold as an FDA-approved drug product. What you pay typically depends on the dose strength, the number of doses prescribed per month, which compounding pharmacy fills the order, and whether your insurer approves an exception request for the medication or the associated psychiatric visits. Our guide to the ketamine tablet prior authorization process walks through how that approval request typically works and what documentation a prescriber usually needs to submit.

Form itself rarely changes the underlying evaluation and monitoring costs, since a prescriber still needs to assess you, set a starting dose, and check in as you titrate, regardless of whether the pharmacy dispenses tablets or capsules.